Lite Strategy, Inc. (LITS)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
0.95 USD
-0.06
(-6.356%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:01 a.m. EDT
The investment case for Lite Strategy, Inc. is fundamentally broken. The company is trading at a fraction of its book value because it is generating massive losses, burning cash, and showing no path to profitability, evidenced by negative returns on assets and equity. The price trajectory confirms this deterioration; the stock has lost over 90% of its value over the last nine years, with five consecutive years of declines ending recently. While there is a narrative of corporate restructuring and new management, the financial reality remains dire with no earnings to support a valuation. The recent price action shows a slight stabilization near the lows, but the lack of volume and the absence of any positive earnings surprise suggest this is merely a pause in a long-term decline rather than a reversal. The options market reflects a desperate, high-risk gamble on a moonshot recovery rather than a rational investment thesis, with traders betting on a 5x to 7x move despite the odds being heavily stacked against it. For a serious investor, this is a value trap where the cheap price is the market's final warning. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.181226 |
| AutoETS | 0.191116 |
| MSTL | 0.192757 |
| AutoTheta | 0.195706 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 69.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.188 |
| Excess Kurtosis | -1.23 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2023-11-15 |
| Last Dividend Date | 2023-11-15 |
| Market Cap | 32,181,034 |
| Beta | 0.05 |
| Previous Name | MEI Pharma, Inc. |
| Website | https://www.litestrategy.com |
As of July 11, 2026, 3:01 a.m. EDT: Speculator positioning is overwhelmingly skewed toward out-of-the-money calls, with massive open interest concentrated at strikes significantly above the current price (e.g., 5.0 and 7.5). This indicates a speculative bet on a massive price expansion rather than a hedge against downside risk, despite the extremely low implied volatility suggesting the market views these moves as highly improbable.
| Date | Dividend | Yield % |
|---|---|---|
| 2023-11-16 | 1.75 | 28.501629 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6905538 |
| Address1 | 9,920 Pacific Heights Blvd. |
| Address2 | Suite 150 |
| All Time High | 15,720.0 |
| All Time Low | 0.69 |
| Ask | 1.17 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 199,220 |
| Average Daily Volume3 Month | 396,447 |
| Average Volume | 396,447 |
| Average Volume10Days | 199,220 |
| Beta | 0.053 |
| Bid | 0.7071 |
| Bid Size | 2 |
| Book Value | 1.617 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.9458 |
| Current Ratio | 11.528 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.9964 |
| Day Low | 0.9149 |
| Display Name | Lite Strategy |
| Dividend Date | 1,701,820,800 |
| Earnings Timestamp | 1,778,675,400 |
| Earnings Timestamp End | 1,778,675,400 |
| Earnings Timestamp Start | 1,778,675,400 |
| Ebitda | -17,126,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.439 |
| Enterprise Value | 24,637,034 |
| Eps Trailing Twelve Months | -2.08 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,700,092,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.9838 |
| Fifty Day Average Change | -0.037999988 |
| Fifty Day Average Change Percent | -0.038625725 |
| Fifty Two Week Change Percent | -69.05538 |
| Fifty Two Week High | 9.0 |
| Fifty Two Week High Change | -8.0542 |
| Fifty Two Week High Change Percent | -0.8949111 |
| Fifty Two Week Low | 0.69 |
| Fifty Two Week Low Change | 0.2558 |
| Fifty Two Week Low Change Percent | 0.37072465 |
| Fifty Two Week Range | 0.69 - 9.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,071,757,800,000 |
| Float Shares | 26,400,833 |
| Free Cashflow | -13,420,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -1,969,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11963 |
| Held Percent Institutions | 0.17318001 |
| Implied Shares Outstanding | 34,025,200 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,700,092,800 |
| Last Dividend Value | 1.75 |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,681,689,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California. |
| Long Name | Lite Strategy, Inc. |
| Market | us_market |
| Market Cap | 32,181,034 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_2214205 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-14 |
| Net Income To Common | -60,820,000 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 32,351,160 |
| Open | 0.982 |
| Operating Cashflow | -10,418,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.22 |
| Phone | 858 369 7100 |
| Prev Name | MEI Pharma, Inc. |
| Previous Close | 1.01 |
| Price Hint | 4 |
| Price To Book | 0.58491033 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.924 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0642 |
| Regular Market Change Percent | -6.35643 |
| Regular Market Day High | 0.9964 |
| Regular Market Day Low | 0.9149 |
| Regular Market Day Range | 0.9149 - 0.9964 |
| Regular Market Open | 0.982 |
| Regular Market Previous Close | 1.01 |
| Regular Market Price | 0.9458 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 302,800 |
| Return On Assets | -0.27686 |
| Return On Equity | -1.59261 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 34,025,200 |
| Shares Percent Shares Out | 0.0041 |
| Shares Short | 140,842 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 153,829 |
| Short Name | Lite Strategy, Inc. |
| Short Percent Of Float | 0.0047999998 |
| Short Ratio | 0.27 |
| Source Interval | 15 |
| State | CA |
| Symbol | LITS |
| Total Cash | 7,544,000 |
| Total Cash Per Share | 0.222 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.4013 |
| Two Hundred Day Average Change | -0.45549995 |
| Two Hundred Day Average Change Percent | -0.32505527 |
| Type Disp | Equity |
| Volume | 302,800 |
| Website | https://www.litestrategy.com |
| Zip | 92,121 |